COM:SOTERAHEALTH
Sotera Health
- Stock
Last Close
12.41
22/11 21:00
Market Cap
3.31B
Beta: -
Volume Today
4.17M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 37.50M - | 35.74M 4.67% | 44.19M 23.63% | 45.72M 3.45% | 42.73M 6.53% | ||
average payables | 44.18M - | 47.20M 6.84% | 62.63M 32.69% | 73.50M 17.35% | 72.59M 1.24% | ||
average receivables | 126.60M - | 101.66M 19.70% | 99.96M 1.67% | 113.33M 13.38% | 133.09M 17.43% | ||
book value per share | 0.18 - | -2.61 1,548.58% | 1.91 173.26% | 2.10 9.76% | 1.25 40.43% | 1.57 25.30% | |
capex per share | -0.29 - | -0.23 21.15% | -0.23 3.22% | -0.37 62.53% | -0.65 77.97% | -0.76 16.57% | |
capex to depreciation | -0.49 - | -0.39 21.10% | -0.37 4.50% | -0.68 81.65% | -1.25 85.08% | -1.36 8.64% | |
capex to operating cash flow | -0.61 - | -0.38 36.74% | -0.44 15.50% | -0.36 18.22% | -0.66 80.82% | 1.46 321.78% | |
capex to revenue | -0.10 - | -0.07 24.41% | -0.07 11.10% | -0.11 67.70% | -0.18 65.68% | -0.20 12.75% | |
cash per share | 0.39 - | 0.26 34.70% | 0.43 68.78% | 0.38 11.16% | 1.41 269.48% | 1.05 26.03% | |
days of inventory on hand | 35.29 - | 35.65 1.02% | 33.22 6.81% | 48.00 44.49% | 30.35 36.77% | 37.35 23.06% | |
days payables outstanding | 43.51 - | 40.04 7.97% | 51.06 27.52% | 64.43 26.19% | 60.58 5.97% | 54.92 9.35% | |
days sales outstanding | 69.27 - | 52.33 24.46% | 40.93 21.79% | 42.39 3.58% | 43.09 1.64% | 51.38 19.24% | |
debt to assets | 0.83 - | 1.10 33.59% | 0.66 39.78% | 0.63 5.40% | 0.63 0.35% | 0.74 18.64% | |
debt to equity | 50.45 - | -4.43 108.79% | 4.04 191.08% | 2.99 25.88% | 5.58 86.38% | 5.24 5.98% | |
dividend yield | 0.03 - | 0.11 293.06% | 0.02 79.44% | ||||
earnings yield | -0.00 - | -0.00 247.96% | -0.01 73.87% | 0.02 409.23% | -0.10 663.21% | 0.01 110.75% | |
enterprise value | 8.32B - | 8.96B 7.74% | 8.24B 8.02% | 8.21B 0.39% | 3.89B 52.63% | 6.80B 74.86% | |
enterprise value over ebitda | 26.28 - | 26.11 0.66% | 30.04 15.06% | 24.46 18.57% | 12.24 49.95% | 24.59 100.80% | |
ev to operating cash flow | 69.59 - | 60.14 13.57% | 68.37 13.68% | 29.17 57.34% | 14.00 52.02% | -46.05 429.01% | |
ev to sales | 11.15 - | 11.52 3.29% | 10.08 12.50% | 8.82 12.51% | 3.88 56.04% | 6.48 67.26% | |
free cash flow per share | 0.19 - | 0.37 95.49% | 0.28 24.32% | 0.64 127.65% | 0.34 46.88% | -1.28 475.28% | |
free cash flow yield | 0.01 - | 0.01 95.49% | 0.01 30.77% | 0.03 165.25% | 0.04 50.17% | -0.08 285.52% | |
graham net net | -9.92 - | -12.42 25.18% | -8.91 28.23% | -7.12 20.11% | -8.08 13.51% | -7.96 1.47% | |
graham number | 0.31 - | 2.21 609.96% | 2.61 18.01% | 4.45 70.67% | 4.84 8.94% | 2.53 47.79% | |
income quality | -20.35 - | -7.30 64.14% | -3.22 55.92% | 2.40 174.74% | -1.19 149.51% | -2.88 141.63% | |
intangibles to total assets | 0.66 - | 0.67 1.58% | 0.64 5.06% | 0.62 3.27% | 0.51 17.09% | 0.49 4.50% | |
interest coverage | 0.56 - | 1.16 106.36% | 0.96 17.78% | 3.46 261.56% | 3.10 10.45% | 1.94 37.51% | |
interest debt per share | 9.67 - | 12.21 26.25% | 8.63 29.36% | 6.55 24.11% | 7.26 10.89% | 8.72 20.11% | |
inventory turnover | 10.34 - | 10.24 1.01% | 10.99 7.31% | 7.60 30.79% | 12.03 58.15% | 9.77 18.74% | |
invested capital | 50.45 - | -4.43 108.79% | 4.04 191.08% | 2.99 25.88% | 5.58 86.38% | 5.24 5.98% | |
market cap | 6.18B - | 6.18B 0% | 6.52B 5.57% | 6.58B 0.82% | 2.33B 64.52% | 4.77B 104.54% | |
net current asset value | -2.35B - | -2.97B 26.35% | -1.99B 32.93% | -1.86B 6.74% | -2.12B 14.27% | -2.13B 0.33% | |
net debt to ebitda | 6.76 - | 8.11 19.94% | 6.28 22.65% | 4.87 22.32% | 4.90 0.53% | 7.34 49.74% | |
net income per share | -0.02 - | -0.08 247.96% | -0.16 90.08% | 0.42 365.39% | -0.83 299.21% | 0.18 121.75% | |
operating cash flow per share | 0.49 - | 0.61 24.65% | 0.51 16.21% | 1.01 98.75% | 0.99 1.58% | -0.52 152.56% | |
payables turnover | 8.39 - | 9.12 8.66% | 7.15 21.58% | 5.67 20.75% | 6.02 6.35% | 6.65 10.31% | |
receivables turnover | 5.27 - | 6.98 32.39% | 8.92 27.86% | 8.61 3.46% | 8.47 1.61% | 7.10 16.14% | |
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.01 - | -0.02 276.82% | -0.04 55.49% | 0.11 391.85% | -0.15 240.29% | 0.03 120.92% | |
revenue per share | 3.03 - | 3.16 4.31% | 3.44 8.86% | 3.34 3.08% | 3.58 7.42% | 3.70 3.39% | |
roe | -0.13 - | 0.03 124.02% | -0.08 359.47% | 0.20 341.80% | -0.67 434.41% | 0.12 117.36% | |
roic | -0.01 - | 1.83 21,702.01% | 0.08 95.43% | 0.07 15.68% | 0.10 41.35% | 0.05 53.17% | |
sales general and administrative to revenue | 0.18 - | ||||||
shareholders equity per share | 0.18 - | -2.61 1,548.58% | 1.91 173.26% | 2.10 9.76% | 1.25 40.43% | 1.57 25.30% | |
stock based compensation to revenue | 0.01 - | 0.01 4.98% | 0.01 51.88% | 0.01 10.88% | 0.02 41.93% | 0.03 45.38% | |
tangible asset value | -1.74B - | -2.37B 36.08% | -1.30B 45.02% | -1.13B 13.16% | -1.24B 9.68% | -1.08B 12.80% | |
tangible book value per share | -7.08 - | -9.64 36.08% | -5.49 43.06% | -4.06 26.07% | -4.44 9.34% | -3.83 13.76% | |
working capital | 169.49M - | 128.36M 24.26% | 174.42M 35.88% | 184.80M 5.95% | -146.56M 179.31% | 326.59M 322.84% |
All numbers in USD (except ratios and percentages)